TLR7 and psoriasis: Preclinical in vivo models of psoriasis and skin inflammation in rodents often use imiquimod (IMQ, a TLR7/8 agonist) which, after application on the skin, gives rise to local inflammation characterised by erythema, swelling, scaling and thickening of the skin similar to psoriasis in the human [27].